Skip to main content

Table 1 Blood tests results of subjects in the 2013 EMIL IIa study

From: Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis

 

BMI < 25 with fatty liver (n = 5)

BMI ≥ 30 without fatty liver (n = 27)

p-value

Mean

SD

Min

Max

Mean

SD

Min

Max

ALT (U/l)

26.0

7.1

19.0

37.0

23.5

7.8

12.0

47.0

0.3627

AST (U/l)

26.4

3.0

23.0

30.0

23.1

4.6

14.0

33.0

0.1235

GGT (U/l)

33.0

14.5

22.0

58.0

38.3

52.3

9.0

279.0

0.2314

AP (U/l)

69.2

18.4

42.0

87.0

71.1

19.4

41.0

133.0

0.9793

Cortisol (µg/dl)

15.5

3.2

10.9

19.4

12.7

6.3

0.6

31.9

0.1880

SHBG (nmol/l)

52.3

22.9

19.8

71.9

60.9

24.4

12.3

121.9

0.5368

Proinsulin (pmol/l)

2.6

2.2

0.7

4.4

2.9

1.9

0.4

7.9

0.6868

Insulin (mU/l)

9.0

3.7

5.8

15.1

9.6

5.4

2.7

27.6

0.9144

Proinsulin/insulin-ratio

0.3

0.3

0.1

0.4

0.3

0.2

0.1

0.9

0.7350

Glucose (mg/dl)

105.0

15.1

87.0

128.0

98.8

11.9

81.0

135.0

0.2749

Fibrinogen (g/l)

2.9

0.7

2.2

4.0

3.6

0.7

2.4

4.9

0.0636

Caeruloplasmin (g/l)

0.22

0.04

0.17

0.27

0.25

0.03

0.17

0.31

0.0682

Serum ferritin (µg/dl)

199.2

72.1

133.0

318.0

106.0

89.6

8.0

408.0

0.0224

Albumin (g/l)

47.0

2.4

45.0

51.0

45.1

2.9

40.0

52.0

0.1359

T3 (nmol/l)

1.8

0.2

1.5

2.1

1.6

0.3

0.8

2.1

0.2065

T4 (nmol/l)

99.1

15.8

72.7

112.5

106.0

23.1

52.5

147.0

0.4361

TSH (mIU/l)

1.3

0.6

0.7

2.1

1.6

1.0

0.4

5.3

0.7270

AntiTPO (IU/ml)

12.6

4.4

7.0

18.0

40.5

79.5

5.0

321.0

0.7465

Cholesterol (mmol/l)

6.2

1.4

4.8

8.4

5.6

1.1

3.2

7.9

0.4992

LDL (mmol/l)

3.8

1.0

2.8

5.4

3.4

0.9

1.4

5.2

0.4660

HDL (mmol/l)

1.5

0.6

0.9

2.5

1.7

0.3

1.2

2.2

0.2733

Triglycerides (mmol/l)

2.6

2.0

1.1

5.7

1.2

0.5

0.3

2.1

0.1244

Iron (µmol/l)

18.1

2.9

14.4

22.0

17.5

9.1

7.5

50.2

0.2325

Transferrin (g/l)

2.7

0.3

2.5

3.2

2.6

0.5

1.9

3.9

0.2974

STFR (mg/l)

2.8

0.4

2.4

3.5

3.8

1.5

2.0

8.9

0.0485

HOMA-IR

2.3

0.7

1.6

3.2

2.3

1.4

0.6

7.4

0.7677

Red blood cells (× 1012/l)

4.8

0.4

4.4

5.4

4.4

0.4

2.9

5.0

0.0931

White blood cells (× 109/l)

5.3

1.2

3.7

7.1

6.2

1.5

4.3

9.2

0.2263

Haemoglobin (g/dl)

14.9

0.8

14.2

16.0

13.5

1.2

9.7

15.7

0.0078

Haematocrit (l/l)

0.44

0.02

0.42

0.47

0.41

0.04

0.29

0.47

0.0227

MCH (pg/pg)

31.4

1.6

29.5

32.8

30.5

1.5

26.5

33.9

0.3467

MCHC (g/dl)

34.0

0.6

33.0

34.6

33.2

0.8

31.4

34.4

0.0293

MCV(fl/fl)

92.6

4.7

86.6

98.3

91.8

3.7

81.9

100.9

0.7676

Platelets (× 109/l)

180.2

59.0

136.0

283.0

214.0

51.0

95.0

332.0

0.0719

HbA1c (%)

5.8

0.7

5.1

7.0

5.7

0.5

5.0

7.4

0.9705

MPV (fl/fl)

10.0

1.6

8.2

11.9

9.2

1.0

7.3

11.2

0.3332

  1. Comparison of the lean NAFLD (BMI < 25 + fatty liver) and non-NAFLD (BMI > 30 and no fatty liver) groups [EMIL, Echinococcus multilocularis and other medical conditions in Leutkirch; SD, standard deviation]
  2. Italic values indicate significance of p values (p < 0.05)